Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05774704
PHASE1/PHASE2

Curcumin and Retinal Study

Sponsor: Texas Tech University Health Sciences Center

View on ClinicalTrials.gov

Summary

To test how two weeks of curcumin supplementation would cross the blood brain barrier (BBB) and attach to amyloid beta proteins, to assess the feasibility (safety and bioavailability), and to explore the resulting abundance/composition of gut microbiota.

Official title: Curcumin and Retinal Amyloid-beta Pilot Study

Key Details

Gender

All

Age Range

40 Years - 89 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2023-08-21

Completion Date

2026-12-31

Last Updated

2026-01-13

Healthy Volunteers

Yes

Interventions

DRUG

Low curcumin group

One curcumin capsule (250 mg curcumin) after each meal, 3 times a day for 2 weeks.

DRUG

High curcumin group

One curcumin capsule (500 mg curcumin) after each meal, 3 times a day for 2 weeks.

Locations (1)

Texas Tech University Health Sciences Center

Lubbock, Texas, United States